Evidence map›Paper›PMID 35889432›Full record

ArticleMolecules (Basel, Switzerland)2022

Synergistic Effect between Amoxicillin and Zinc Oxide Nanoparticles Reduced by Oak Gall Extract against

Hany G Attia, Hassan A Albarqi, Ismail G Said, Omaish Alqahtani, Mohamed A Ei Raey

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Influence ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Novel Drug Delivery Systems for CombatingArchives of Razi Institute · 2024
    Review
  7. Review
  8. Phytochemical Profiling and Biological Activities ofPlants (Basel, Switzerland) · 2023
    Review
  9. Metal-Based Nanoparticles: A Prospective Strategy forInternational journal of nanomedicine · 2023
    Review
  10. Article
  11. Frontiers in pharmacology · 2023
    Article
  12. Green Synthesized Zinc Oxide Nanoparticles Based onMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hany G AttiaDepartment of Pharmacognosy, College of Pharmacy, Najran University, Najran 1988, Saudi Arabia.ORCID 0000-0002-4494-8309
Hassan A AlbarqiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 1988, Saudi Arabia.ORCID 0000-0002-1902-2328
Ismail G SaidDepartment of Chemistry of Natural and Microbial Products, National Research Centre, Dokki, Cairo 12311, Egypt.
Omaish AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, Najran University, Najran 1988, Saudi Arabia.ORCID 0000-0003-2237-740X
Mohamed A Ei RaeyDepartment of Phytochemistry and Plant Systematics, National Research Centre, Dokki, Cairo 12311, Egypt.ORCID 0000-0002-5960-3012
Najran University · SANational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsHelicobacter pyloriMetal NanoparticlesNanoparticlesQuercusZinc OxideAmoxicillinAnti-Bacterial AgentsChromatography, LiquidPlant ExtractsTandem Mass SpectrometryAmoxicillinAnti-Bacterial AgentsAnti-Infective AgentsPlant ExtractsZinc Oxidecheckerboard assayHelicobacter pyloriLC-MS/MSOak gallszinc oxide nanoparticles

Identifiers

PMID35889432
PMCPMC9320066
OpenAlexW4285731557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.